Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial mapping, isolation, and culture of primary human microglia and astrocytes: A systematic review and framework for glial cell-based models.

Journal of neuropathology and experimental neurology·2026
Same author

Eucalyptol Ameliorates Neuroendocrine Stress-Aggravated Rheumatoid Arthritis Through Anti-inflammatory, Antioxidant, and Chondroprotective Mechanisms Associated with NF-κB and MAPK Signaling Pathways.

Cureus·2026
Same author

QIM26-290: Harnessing Artificial Intelligence for Quality Improvement: The RESCUE Score - A First-of-Its-Kind AI Framework for Quality Evaluation and Outcome Correlation in Resource-Limited Bone Marrow Transplantation Programs.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

CD163 Outperforms CD68 in Clear Cell Renal Cell Carcinoma: Clinicopathological and Prognostic Correlations.

Annals of African medicine·2026
Same author

QIM26-290: Harnessing Artificial Intelligence for Quality Improvement: The RESCUE Score - A First-of-Its-Kind AI Framework for Quality Evaluation and Outcome Correlation in Resource-Limited Bone Marrow Transplantation Programs.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Medical guidelines for fibrodysplasia ossificans progressiva.

JBMR plus·2025
Same journal

Risk stratification in conservatively treated pediatric lateral humeral condyle fractures: the prognostic value of articular gap and initial displacement - a retrospective cohort study.

Journal of pediatric orthopedics. Part B·2026
Same journal

Surgical management of unstable juvenile osteochondritis dissecans of the knee: clinical outcomes, return to sport, complications, and reoperation rates with an average follow-up of 6.5 years.

Journal of pediatric orthopedics. Part B·2026
Same journal

Reliability of the Beit CURE classification for the management of chronic hematogenous osteomyelitis of the long bones in children.

Journal of pediatric orthopedics. Part B·2026
Same journal

Surgical outcomes for displaced lateral humeral condyle fractures in children: a retrospective study comparing two types of tension band wiring procedures and pinning.

Journal of pediatric orthopedics. Part B·2026
Same journal

Finding the physeal midpoint for distal femoral hemiepiphysiodesis utilizing novel anatomic measurements.

Journal of pediatric orthopedics. Part B·2026
Same journal

Association between vitamin D deficiency and adolescent idiopathic scoliosis.

Journal of pediatric orthopedics. Part B·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Establishment and Evaluation of a Sheep Model of Full-thickness Osteochondral Defect
05:23

Establishment and Evaluation of a Sheep Model of Full-thickness Osteochondral Defect

Published on: April 14, 2026

162

Triphasic ceramic scaffold in paediatric and adolescent bone defects.

Balasubramanian Balakumar1, Suresh Babu, Harikrishna K Varma

  • 1aPaediatric Orthopaedic Unit, Christian Medical College, Vellore, Tamil Nadu bBioceramic Laboratory, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India.

Journal of Pediatric Orthopedics. Part B
|November 9, 2013
PubMed
Summary
This summary is machine-generated.

This study found that the synthetic bone graft hydroxyapatite tricalcium phosphate calcium silicate scaffold (HASi) is safe for certain pediatric bone defects. Younger age and cancellous defects showed faster healing, but HASi is not recommended for diaphyseal or segmental defects.

More Related Videos

Use of Human Perivascular Stem Cells for Bone Regeneration
07:05

Use of Human Perivascular Stem Cells for Bone Regeneration

Published on: May 25, 2012

23.2K
Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect
09:35

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Published on: September 11, 2015

10.8K

Related Experiment Videos

Last Updated: May 6, 2026

Establishment and Evaluation of a Sheep Model of Full-thickness Osteochondral Defect
05:23

Establishment and Evaluation of a Sheep Model of Full-thickness Osteochondral Defect

Published on: April 14, 2026

162
Use of Human Perivascular Stem Cells for Bone Regeneration
07:05

Use of Human Perivascular Stem Cells for Bone Regeneration

Published on: May 25, 2012

23.2K
Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect
09:35

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Published on: September 11, 2015

10.8K

Area of Science:

  • Biomaterials Science
  • Orthopedic Surgery
  • Pediatric Orthopedics

Background:

  • Pediatric bone defects require effective management strategies.
  • Synthetic bone substitutes offer an alternative to autografts, potentially reducing donor site morbidity.
  • Hydroxyapatite tricalcium phosphate calcium silicate scaffold (HASi) is a novel synthetic material for bone regeneration.

Purpose of the Study:

  • To evaluate the safety and efficacy of the HASi scaffold in treating pediatric bone defects.
  • To identify factors influencing healing rates and complications associated with HASi use.
  • To determine the suitability of HASi for various types of pediatric bone defects.

Main Methods:

  • A prospective study involving 42 children under 16 years old with various bone defects.
  • HASi was used as a standalone graft for pelvic, femur, calcaneal, and ulnar osteotomies, cystic lesions, arthrodesis, and segmental defects.
  • Follow-up included clinical and radiographic assessment of healing and complications over a mean of 18.51 months.

Main Results:

  • Forty children were evaluated, with a mean age of 8.3 years.
  • Faster healing was associated with younger age, cancellous defects, and absence of internal fixation.
  • Complete incorporation of HASi was observed in 77.5% of cases by 18 months; complications included four nonunions, primarily in diaphyseal defects.

Conclusions:

  • HASi is a safe and effective bone substitute for pediatric cancellous or benign cavitatory bone defects.
  • The material is not suitable as a standalone graft for diaphyseal and segmental bone defects.
  • Further research may explore modifications or combination therapies for complex pediatric bone defects.